VIP

Also known as: Vasoactive Intestinal Peptide, Aviptadil

ImmunePHASE 2

Clinical Status

Clinical trials — multiple indications.

Mechanism of Action

Binds to VPAC1 and VPAC2 receptors, triggering anti-inflammatory cascades. Relaxes smooth muscle, vasodilates, and promotes regulatory T-cell function.

Dosing Defaults

Dose

50-100 mcg

Frequency

1-2x daily

Administration

Intranasal

Timing

Morning

Food

with or without

Duration

Variable

Dose range: 25-150 mcg daily

Morning dosing supports daytime anti-inflammatory effects.

Side Effects

•Nausea
•Diarrhea
•Headache
•Dizziness
•Facial flushing
•Blood pressure decrease

Contraindications & Warnings

•Not medical advice

Compare

Compare VIP with another peptide side-by-side.

Calculate Dose

Use the reconstitution calculator to prepare your VIP dose.

Open Calculator

Related Immune Peptides

LL-37

PHASE 1

Immune

Antimicrobial peptide with broad-spectrum activity and wound healing properties.

KPV

PRECLINICAL

Immune

Anti-inflammatory peptide fragment. Does NOT cause immunosuppression.

Thymosin Alpha-1

PHASE 3

Immune

Thymic peptide for immune modulation. Approved in 35+ countries.

Thymulin

PRECLINICAL

Immune

Zinc-dependent thymic peptide that promotes T-cell maturation and immune balance.

This information is for educational purposes only and is not medical advice. Dosing data is based on research literature and community reports. Always consult a qualified healthcare provider before using any peptide.